Full Text
PCN67 COST-UTILITY OF KRAS MUTATION TESTING PRIOR TO TREATMENT OF METASTATIC COLORECTAL CANCER WITH CETUXIMAB MONOTHERAPY

Abstract

Authors

JJ Carlson

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×